Search

Copyright of Revista Latinoamericana de Hipertension is the property of Revista Latinoamericana de Hipertension and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Revista Electrónica de Psicología Iztacala is the property of Facultad de Estudios Superiores Iztacala and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Revista Foco (Interdisciplinary Studies Journal) is the property of Revista Foco and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introduction: An important risk factor to achieve an adequate control of a chronic disease is the knowledge that the patient has about his disease. Several studies have shown a relationship between the type 2 diabetes mellitus patient’s knowledge and their treatment adherence or hemoglobin A1c levels. The objective of this article was to evaluate how much patients with type 2 diabetes mellitus know about their disease. Method: A systematic review of the scientific literature was conducted following the 2020 Prisma statement on the databases: Medline, Scopus, CINAHL and PsychINFO. Randomized clinical trials, quasi-experimental, cross-sectional and control and case studies published until April 1 of 2024 were included. The screening, extraction, and the risk of bias assessment was done by 2 researchers independently. Results: 35 articles were included (29 cross-sectional, 4 randomized clinical trials and 2 quasi-experimental). The portion of patients with adequate knowledge of type 2 diabetes mellitus varies with the tool used to assess the knowledge, but in general, less than 45 % of the patients had adequate knowledge about their disease. Conclusions: This systematic review identified that most patients with type 2 diabetes mellitus have a deficient knowledge of their disease, only 2 articles showed samples with adequate knowledge. [ABSTRACT FROM AUTHOR]

Copyright of Gaceta Médica de Caracas is the property of Academia Nacional de Medicina and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Revista Foco (Interdisciplinary Studies Journal) is the property of Revista Foco and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Es importante ver que, con el pasar del tiempo y el crecimiento acelerado del conocimiento de la mano de la tecnología, un mundo interrelacionado por las comunicaciones hace que se vayan consolidando saberes, cuestionando y mejorando conceptos en pro del ser humano, de tal manera que se plantean subgrupos en la clasificación de la diabetes. Estos subgrupos demuestran patrones distintos clínicamente, con comorbilidades, progresión de enfermedad, complicaciones y mayor riesgo de enfermedades cardiovasculares, renales e hígado graso. Se plantea, por supuesto, que cada individuo se ubica en un punto del espectro de variación fenotípica, determinado por su genética y mezcla de lo no genético, lo que representa su salud metabólica y estado de diabetes. En la revisión narrativa realizada por los doctores Matta Herrera y Mendoza-Fuentes, en esta edición de la revista, se enfatizó en la importancia de una clasificación adecuada, con el fin de dar más precisión en tratamientos y se planteó con esto, prevención de complicaciones y disminución de costos.

Introduction: Cardiovascular disease is the main cause of mortality in people with type 2 diabetes mellitus. Objective: Design a predictive model of macrovascular complications in patients with type 2 diabetes at the time of diagnosis. Methods: An observational, of cases and controls, retrospective study was carried out. The population studied were all patients diagnosed with type 2 diabetes mellitus in the "José Martí" health area of the province of Santiago de Cuba, during the period from September 2018 to December 2022. 40 cases with macrovascular complications and 80 controls were studied. randomly selected from the same population, without complications. To build the model, binary logistic regression was applied and those that were associated with macrovascular complications in a previous bivariate analysis were used as independent variables. Results: The variables that were included in the model, after the binary logistic regression analysis, were arterial stiffness, hyperlipidaemia, and arterial hypertension. Hosmer-Lemeshow test= 6.027; p= 0.644. The sensitivity of 77.50 % and specificity of 90.00 %; with a positive predictive value of 79.49 and negative predictive value of 88.89; and validity index equal to 85.83. The observed area under the Receiver Operating Characteristic curve is 0.933, with a significance associated with the calculated statistic of 0.000. Conclusions: The designed model is a good predictor of macrovascular complications in patients with type 2 diabetes at the time of diagnosis.

Resumo Introdução: A atenção ao paciente com Diabetes Mellitus (DM) envolve uma multiplicidade de procedimentos ambulatoriais visando à redução do risco de complicações. Objetivo: Estimar as prevalências e incidências das complicações do DM e analisar a oferta e a demanda de procedimentos ambulatoriais. Método: Estudo retrospectivo e transversal utilizando dados da Pesquisa Nacional de Saúde (PNS-2013) e do Sistema de Informações Ambulatoriais do SUS (SIA/SUS) para: (1) calcular estimativas de prevalências e incidência do DM e suas complicações crônicas; (2) caracterizar o cuidado ao paciente com DM; e (3) analisar a oferta e a demanda de procedimentos ambulatoriais relacionados ao DM e complicações crônicas segundo as regiões de saúde do Amazonas (AM) e do Rio Grande do Sul (RS) para o ano de 2012. Resultados: No RS, em comparação ao AM, encontraram-se maiores incidências de complicações crônicas, maior proporção de internações, maior uso de emergências e menor procura regular por acompanhamento médico. Exames de baixa complexidade apresentaram oferta superior à demanda esperada e aqueles de maior complexidade apresentaram volume inferior ao preconizado. Conclusões: A demanda de cuidados observada para DM foi superior à oferta. Este é um importante indicador de monitoramento a ser utilizado no planejamento das ações da atenção primária.

N/a.

La diabetes mellitus tipo 2 es una enfermedad crónica multifactorial, caracterizada por la presencia de una resistencia a la insulina generada por una disfunción de las células beta. La enfermedad de Alzheimer es considerada como la enfermedad neurodegenerativa más frecuente de las demencias, se caracteriza por un deterioro progresivo y persistente de la función cognitiva global. A través de investigaciones epidemiológicas se observa que la diabetes mellitus tipo 2 se asocia con un mayor riesgo de deterioro cognitivo y su progreso hacia la demencia, con mayor frecuencia a una demencia tipo Alzheimer. La revisión bibliográfica se basó en la utilización de la metodología PICO para extraer información actualizada sobre la influencia que ejerce la diabetes mellitus tipo 2 sobre la demencia tipo Alzheimer, de artículos actualizados publicados los últimos cinco años, en la base de datos BVS y PubMed. Para el respectivo análisis, se eligieron 13 artículos, trabajos investigativos que exploraron la relación de estas dos enfermedades por medio de test neurológicos, análisis del ADN mitocondrial y resonancia magnética. Los 13 artículos científicos evidenciaron, que la diabetes mellitus tipo 2 tiene una influencia significativa en el desarrollo de la enfermedad de Alzheimer, debido a los cambios cognitivos demostrados.

Objetivo: Evaluar las estrategias de fomento de la salud en pacientes con diabetes mellitus tipo 2 de las unidades de salud familiar del distrito de Limpio, Paraguay, 2022. Metodología: Enfoque cuantitativo, descriptivo de tipo observacional, con dos valoraciones secuenciales. Fueron seleccionados 299 sujetos del Programa de Prevención y Modelo de Cuidados Crónicos para las Unidades de Salud Familiar de Limpio, proyecto de la agencia koica, “hefa ‘Salud para Todos’”, en particular del subprograma de pacientes crónicos con diabetes mellitus tipo 2, de 19 unidades de salud familiar de la ciudad de Limpio. Se utilizaron los datos registrados en el programa informático del Proyecto. Se caracterizaron los pacientes incluidos y, posteriormente, se describieron las orientaciones dadas por los médicos como estrategia para el fomento de la salud. Además, se realizaron dos valoraciones (antes/después) en cuanto a medidas antropométricas. Resultados: Del total de 299 sujetos con diabetes mellitus tipo 2 que cumplieron con los criterios de inclusión y exclusión, el 15,72 % contaba con antecedente de diabetes. Respecto a las orientaciones, el 45,82 % recibió algún tipo de orientación sobre hábitos saludables, 38,46 % sobre actividad física, 11,71 % sobre consumo de alcohol y 35,45 % sobre el consumo de medicamentos. Solo se registraron dos casos de complicaciones, los cuales correspondieron a pie diabético. Se registró que no hubo un cambio de hábitos entre la primera y última consulta para el hábito de ejercicios. Conclusión: En cuanto a las estrategias de fomento de la salud que se encontraron desde la perspectiva de la salud pública, este programa se enfocó a orientaciones y educación permanente de los pacientes en cada consulta, haciendo seguimiento del cumplimiento de las mismas

Nonalcoholic fatty liver disease or metabolic-associated fatty liver disease (MAFLD) is a common condicion with increasing prevalence and incidence, specially in patients with type 2 diabetes mellitus (T2DM). Both cardiovascular and renal disease are clearly increased in these patients, particularly in those with diabetic nephropathy. In the liver-heart-kidney-metabolic axis, the common pathophysiological basis of MAFLD, cardiovascular disease (CVD), chronic kidney disease (CKD), and T2DM is the same. The clinical relationship between all of them is clear and is multidirectional: MAFLD may precede the development of cardiovascular and renal disease, and may also worsen the prognosis of these complications once developed. In this review we emphasize the importance of targeting MAFLD in Diabetic kidney disease, with the goal of detecting high-risk patients in order to improve their prognosis. Resumen: La incidencia y prevalencia de hígado graso no alcohólico o enfermedad hepática metabólica (EHmet) está en aumento y es mayor en pacientes con diabetes mellitus tipo 2 (DM2). El riesgo cardiovascular y renal está claramente incrementado en estos pacientes, especialmente cuando se desarrolla nefropatía diabética. El eje cardio-reno-hepato-metabólico, conformado por la enfermedad cardiovascular (ECV), la enfermedad renal crónica (ERC), la EHmet y la DM2, tiene una base fisiopatogénica común. La relación clínica entre todos los componentes es inevitable y multidireccional, pudiendo la EHmet preceder al desarrollo de complicaciones cardiovasculares y renales, y también empeorar el pronóstico de las mismas una vez desarrolladas. En esta revisión enfatizamos la importancia de buscar y tratar la EHmet en pacientes con ERC de la DM2 con el objetivo de identificar pacientes de mayor riesgo y de mejorar su pronóstico.

La prevalencia de la diabetes mellitus tipo 2 (DMT2) está aumentando de forma exponencial en todo el mundo, habiéndose comprobado que estos pacientes tienen mayor riesgo de presentar fracturas óseas, con respecto a la población sana, por lo que resulta de gran relevancia el conocimiento del efecto de los fármacos antidiabéticos sobre el metabolismo óseo.

Copyright of Revista Tecno Lógicas is the property of Instituto Tecnologico Metropolitano and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Dilemas Contemporáneos: Educación, Política y Valores is the property of Dilemas Contemporaneos: Educacion, Politica y Valores and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introduction: The Adherence to Refills and Medications Scale questionnaire (ARMS) was designed to measure adherence to treatment. It was translated and adapted into Spanish, but its psychometric properties have not been evaluated. The aim was to evaluate these properties in a population with type 2 diabetes mellitus. Method: The study was carried out in community pharmacies in Granada (Spain) by interview. A principal component factor analysis (PCA) with Varimax rotation (construct validity), a concordance analysis (concurrent criterion validity and reliability by temporal stability) and Cronbach’s alpha and item-total correlation (reliability by homogeneity) were performed. Results: 107 patients entered the study. 54.2 % (58) were male and the mean age was 70.5 (SD: 9.7). The PCA extracted 4 factors that explained 57.49 % of the total variance. Cronbach’s alpha= 0.428, and in the test-retest κ= 0.627 (p > 0.001). Conclusions: The ARMS-e cannot be considered a useful tool to measure adherence to oral antidiabetic treatment in this sample. [ABSTRACT FROM AUTHOR]

Objective: To identify the risk factors based on clinical, echocardiographic and therapeutic parameters which predict the development of cardiac complications among patients with diabetes and acute myocardial infarction (AMI). Materials and methods: An observational, analytical, case-control study was conducted at Centro de Cardiología y Cirugía Cardiovascular de Santiago de Cuba, attached to Hospital Provincial Saturnino Lora, from 2019 to 2021. The sample consisted of 266 patients, chosen by simple random sampling 1:2. The study included demographic, clinical- echocardiographic and therapeutic variables. A multivariate analysis was performed with all the variables considered as risk factors; one-way analysis of variance and binary logistic regression were used. Results: The most frequent cardiac complications were atrial fibrillation and heart failure (approximately 12 %). A metabolic control analysis on admission yielded altered results (OR = 6.92; LI: 2.61; LS: 18.32; p = 0.001). The univariate analysis showed that ten factors increased the risk of complications, including the diagnosis of diabetes mellitus ≥ 10 years (OR = 2.50; LI: 1.14; LS: 5.45; p = 0.020). On the other hand, the multivariate analysis revealed six factors that predict the development of cardiac complications: age ≥ 60 years (OR = 5.624; CI = 1.607-19.686; p = 0.007), altered metabolic control on admission (OR = 5.245; CI = 1.491-18.447; p = 0.010), lack of use of thrombolytic therapy (OR = 5.74; CI = 1.46-22.586; p = 0.012), left ventricular ejection fraction (LVEF) ≤ 40 % (OR = 5.245; CI = 1.17-23.433; p = 0.030), left atrial pressure ≥ 15 mmHg (OR = 12.335; CI = 3.45-44.08; p = 0.001) and motility ≥ 1.5 points (OR = 4.702; CI = 1.258-17.575; p = 0.021). Conclusions: The study demonstrated the value of six risk factors of cardiac complications among patients with diabetes and AMI, where glycemic control on admission, decreased LVEF, increased left atrial pressure and no reperfusion therapy stand out. [ABSTRACT FROM AUTHOR]

The present study aimed to map educational technologies for administering insulin therapy in adults with type 2 diabetes mellitus treated by health services. This was a scoping review based on the methodological framework developed by JBI and the checklist of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. A search was carried out in databases and gray literature. The articles were evaluated in a paired and independent manner by two reviewers. For the selection and screening of studies, the Rayyan® reference manager was used. Data were summarized with a table and discussion in thematic categories. Although different educational technologies address the topic of insulin therapy, further studies are needed to evaluate the effects and feasibility of using such technology within the scope of insulin therapy. [ABSTRACT FROM AUTHOR]

Copyright of Acta Médica Peruana is the property of Colegio Medico del Peru and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Revista Foco (Interdisciplinary Studies Journal) is the property of Revista Foco and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Revista Foco (Interdisciplinary Studies Journal) is the property of Revista Foco and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Revista Mexicana de Endocrinología, Metabolismo y Nutrición is the property of Publicidad Permanyer SLU and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Gaceta Médica de Caracas is the property of Academia Nacional de Medicina and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The prevalence of chronic metabolic diseases in Mexico is high, being type 2 Diabetes mellitus (T2DM) as the most common disease. Several studies have shown that, compared with healthy individuals, patients with T2DM suffer a higher severity and mortality of Coronavirus disease 2019 (COVID-19). Therefore, it is important to the knowledge of the bidirectional relationship between these diseases. T2DM can increase SARS-CoV-2 virus pathogenicity in part due to metabolic disturbance. As a result, COVID-19 susceptibility and severity rise in diabetic individuals, which makes them a high-risk population. On the other hand, the infection caused by SARS-CoV-2 can lead individuals to hyperglycemia or new-onset diabetes. In order to understand the relationship between COVID-19 and T2DM, this review aims to emphasize the tropism of the SARS-CoV-2 virus to pancreatic beta-cells, as well as the physiologic effects of these. [ABSTRACT FROM AUTHOR]

Introduction: With the changes in lifestyle and demands of modern society, the reduction of sleep duration and quality has become common, parallel to the increase in the prevalence of obesity and chronic noncommunicable diseases. Objective: To describe sleep duration and quality and relate them to body mass index, waist circumference and body fat percentage in patients with chronic noncommunicable diseases. Materials and methods: This was a cross-sectional study with patients assisted at a Nutrition outpatient clinic. Sleep duration and quality were assessed using a questionnaire. The variables age, sex, height, body mass index and waist circumference were obtained from the service's standard anamnesis. Weight and fat mass were obtained by bioelectrical impedance. The association between self-reported sleep duration and quality with body mass index, waist circumference and fat mass were tested. A significance level of 5% was considered statistically significant. Results: Sixty-nine patients were evaluated, mostly female (66.7%) and adults (58%). Mean sleep duration was 6.81 hours. The majority (34.8%) of the patients reported always having a good quality of sleep, with this percentage being higher among men than among women (p=0.0077). There was no association between sleep duration or quality and anthropometric variables. Conclusion: Despite the low mean duration of sleep of the participants, there was no association between self-reported duration and quality of sleep with the anthropometric variables evaluated. [ABSTRACT FROM AUTHOR]

The rising prevalence of diabetes among older adults is an increasing concern in the United States and is expected to nearly triple within the next 40 years. The purpose of this study was to investigate whether the utilization of Medicare Annual Wellness Visits (AWVs) is associated with changes in type 2 diabetes (T2D) outcomes among older adults Medicare beneficiaries. We conducted an observational retrospective cohort study to compare the T2D outcomes between those who attended AWVs and those who did not from 2017 to 2019. The criteria used for this study include having at least two readings (hemoglobin A1c [A1c] levels, glucose levels, and the number of T2D medications), and for the AWV cohort, the AWVs had to occur between those readings. A total of 508 (2%) Medicare beneficiaries fit our selection criteria. Only 154 (30%) of these patients with T2D participated in AWVs. At baseline, the AWV cohort had lower A1c levels and fewer comorbidities than the non‐AWV cohort. No other statistically significant findings were found. These findings indicate that providers did not utilize AWVs on the more complicated patients, who may need it the most. Key points: We investigated whether the utilization of Annual Wellness Visits (AWVs) is associated with changes in diabetes outcomes in people with type 2 diabetes among older adults Medicare beneficiaries.We found that individuals with more complicated diabetes are receiving fewer AWVs than those with less complicated diabetes. These more complicated diabetes individuals may benefit the most from preventive care because a resulting AWV care plan may provide an opportunity to outline changes in diabetes medications and education leading to fewer diabetes‐related complications.Future study is needed to determine strategies that increase the number of people with complicated diabetes receiving AWVs. [ABSTRACT FROM AUTHOR]

Copyright of Gaceta Médica de México is the property of Publicidad Permanyer SLU and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Arquivos Brasileiros de Oftalmologia is the property of Arquivos Brasileiros de Oftalmologia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Nefrologia is the property of Revista Nefrologia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

La diabetes mellitus tipo 2 es una enfermedad crónica no transmisible, causada por un trastorno en el metabolismo de la glucosa, que provoca un aumento anormal de su concentración en la sangre. El diagnóstico tardío de esta enfermedad contribuye al aumento de las tasas de morbilidad y mortalidad a nivel mundial. El desarrollo de modelos basados en inteligencia artificial para la predicción de diabetes podría acelerar el diagnóstico. Por tanto, el objetivo del presente estudio fue implementar un modelo de predicción de diabetes mellitus tipo 2 basado en mapas cognitivos difusos entrenado con un algoritmo genético. La metodología empleada consistió en utilizar un conjunto de datos del Instituto Nacional de Diabetes y Enfermedades Digestivas y Renales de la población de indios PIMA, que contiene información demográfica y clínica de 768 pacientes. El 70 % de los datos se empleó para el entrenamiento y validación, y el 30 % restante se utilizó para las pruebas de rendimiento. El modelo de mapas cognitivos difusos puede predecir la enfermedad con un 99 % de exactitud, 98 % de precisión y recall de 100 %. Se concluye que el modelo presenta una buena capacidad para predecir y evaluar el comportamiento de las variables de interés en la diabetes mellitus tipo 2, mostrando su valor como herramienta de soporte en la identificación oportuna de la enfermedad y apoyo a la toma de decisiones por parte del profesional médico.

Introducción. Los cuestionarios TBQ evalúan la carga de trabajo que implican los tratamientos recomendados a las personas con condiciones crónicas. En Argentina se encontraba disponible la versión para ser administrada a través de un entrevistador a pacientes con diabetes tipo 2, sin que contáramos con una versión contestable en forma autónoma por el propio paciente. Objetivos. Validar una variante autoadministrada del cuestionario TBQ para medir la carga del tratamiento de personas con diabetes tipo 2, evaluando su comprensibilidad y su desempeño psicométrico. Métodos. Investigación cuali-cuantitativa, con análisis factorial exploratorio (AFE). La validez de criterio concurrente fue evaluada con tres escalas (OMS-5, PHQ-9, Índice de Adherencia de Morisky-Green-Levine). La consistencia interna fue evaluada a través del coeficiente alfa de Cronbach. Resultados. Participaron 100 personas, 38% con escolaridad primaria completa, 47% con enfermedad de menos de cinco años de antigüedad y 70% recibiendo tratamiento por vía oral en forma exclusiva. De manera concordante con la versión validada previamente, el AFE agrupó los ítems en cuatro dominios con fuerte correlación entre sí: 1) tratamiento farmacológico; 2) asistencia sanitaria/sistema de salud; 3) mantenimiento de un estilo de vida y su repercusión económica; 4) repercusión psicosocial de la enfermedad. Documentamos una correlación inversa entre el puntaje TBQ y el de bienestar OMS-5 (-0,4308; p=0,0014) y directa con el de depresión PHQ-9 (+0,3452; p=0,0122). Las personas categorizadas como no adherentes al tratamiento (escala Morisky-Green-Levine) arrojaron en promedio un resultado de 18,24 (intervalo de confianza del 95% 1,82 a 34,68; p=0,03) puntos más en la escala TBQ-diabetes que las adherentes. El coeficiente Alfa de Cronbach fue 0,890 para el factor 1, 0,764 para el 2, 0,673 para el 3 y 0,709 para el 4. Conclusiones. La versión autoadministrada del cuestionario TBQ-diabetes para evaluar la carga de trabajo en personas con diabetes tipo 2 fue adecuadamente comprendida y mostró satisfactorias propiedades psicométricas.

Objetivo. Identificar los factores de riesgo asociados a la Diabetes Tipo 2 en trabajadores de la salud. Materiales y métodos. Revisión sistemática de 32 artículos originales en inglés y español, publicados durante el período de enero desde 2018 a diciembre de 2023. Los estudios elegidos abarcan desde la prevención de esta enfermedad hasta la identificación de factores de riesgo en distintos entornos laborales, incluyendo artículos de revisión, metaanálisis, estudios cuantitativos, así como ensayos clínicos controlados. El proceso de tamizaje incluyó herramientas de control de calidad y lectura crítica de las publicaciones (plantillas CASPe), se excluyeron artículos en bases de datos previos a 2018, no disponibles en formato completo para su descarga, baja calidad metodológica, la irrelevancia del estudio o para la pregunta de investigación, o la presencia de sesgos que podrían afectar la validez de los resultados. Resultados. Se obtuvieron 84 artículos, quedando un total de 32 que cumplieron con criterios de selección posterior a lectura crítica de texto completo. Entre los principales factores de riesgo se encuentran los hábitos alimenticios, patrones de sueño, actividad física, estrés, ansiedad, depresión, falta de tiempo para esparcimiento y predisposición genética, pueden desencadenar desregulaciones metabólicas que predisponen a la resistencia a la insulina y, eventualmente, a la diabetes. Conclusiones. Los factores de riesgo que presenta los trabajadores de la salud derivado de sus estilos de vida relacionados con su trabajo y sus centros laborales son multicausales, para su prevención se requiere de programas de salud laboral que promueva estilos de vida saludables.

Objetivo: Avaliar o conhecimento sobre Diabetes Mellitus tipo 2. Métodos: Estudo transversal com abordagem quantitativa com 360 portadores de Diabetes Mellitus tipo 2. A coleta dos dados foi realizada através do questionário Escala de Conhecimento de Diabetes. Para análise foi utilizada a regressão de Poisson, modelagem hierarquizada e estimação das razões de prevalências. Resultados: A média da idade foi de 61,85 anos (±10,99), o sexo feminino teve 71,94%, a cor parda foi de 59,72%, a ocupação de 48,89% para aposentados/pensionistas, renda familiar de 1 a 2 salários mínimos 62,50%, a escolaridade de 43,06% com ensino fundamental, 57,22% viviam com companheiro e 35,56% possuíam o diagnóstico de diabetes mellitus de 5 a 14 anos, a maioria possuía comorbidades 80,28%, mais da metade não apresentava complicações 68,06% e cerca de 48,89% usavam medicações antidiabéticas. Dos entrevistados 71,67% obtiveram escores superiores a 8, indicando um grau elevado de conhecimento sobre a doença, houve associação estatística com o tempo de diagnóstico de 5 a 14 anos (p: 0,034), tempo de diagnóstico de 15 a 24 anos (p: 0,043) e faixa etária de 40 a 59 anos (p:

Objetivo: determinar la prevalencia de la neuropatía periférica (NP) dolorosa y asintomática en personas con diabetes mellitus tipo 2 (DM2) y sus características asociadas. Materiales y métodos: estudio transversal-descriptivo de pacientes del programa de pie en riesgo del Servicio de Endocrinología del Hospital Nacional María Auxiliadora (HMA). Se incluye a pacientes con DM2 atendidos entre el 2015 y el 2020. La definición de NP fue según el Consenso de Toronto, que considera la evaluación de tres componentes: síntomas, signos y reflejo aquíleo, calificando la certeza como posible y probable, según su combinación. Para la evaluación de síntomas se aplicó el puntaje total de síntomas (TTS, del inglés Total Symptom Score); para los signos se usó la prueba de monofilamento y se evaluó la sensibilidad vibratoria con diapasón de 128 Hz. La prevalencia de NP se calculó según sintomatología y la certeza del diagnóstico. Además, se describieron las características clínicas entre los grupos. Resultados: se incluyó a 1006 personas con una edad media de 60,5 años, de las cuales el 69,3% correspondió a mujeres. En aquellos que tenían al menos un criterio de Toronto (neuropatía posible y probable), un 60,5% presentó NP dolorosa y un 21,8% NP asintomática. Utilizando una mayor certeza diagnóstica, es decir, dos de tres criterios positivos (solo neuropatía probable), la prevalencia de NP dolorosa fue del 42,2% y la NP asintomática, 6,5%. Se establecieron cuatro grupos que presentaron distribuciones diferentes respecto a sexo, tiempo de diabetes, antecedente de úlcera, enfermedad arterial periférica y control glicémico. Conclusión: en pacientes del Servicio de Endocrinología del HMA, el 42,2 y el 6,5% presentaron una mayor certeza de presentar NP probable dolorosa y asintomática respectivamente. Se requiere estudios que confirmen la utilidad de estos criterios para estimar correctamente la carga de enfermedad.

Introducción: la enfermedad por pie diabético es un desenlace indeseado en el curso de esta enfermedad y es necesario caracterizar clínicamente a los pacientes locales, además de conocer qué factores se asocian al requerimiento de amputación. Objetivo: determinar las características clínicas y los factores asociados a amputación de los pacientes con enfermedad por pie diabético. Metodología: este es un estudio retrospectivo de corte transversal basado en la revisión de 154 historias clínicas de pacientes que acudieron al servicio de Urgencias del Hospital Departamental de Villavicencio, en Colombia, en el periodo de julio del 2022 a junio del 2023. En este proceso se recopilaron los siguientes datos: edad, sexo, antecedentes, sitio de residencia, glicemia, hemoglobina glicosilada, creatinina, tipo y nivel de amputación. Resultados: de los 154 pacientes incluidos, 84 (54,50?%) fueron hombres; la edad promedio fue de 64,2 años; 41 pacientes (26,60?%) tenían residencia rural; 76 (49,30?%) fueron amputados, de los cuales, a 32 (20,70?%) les amputaron un dedo, a 15 (9,70?%) le realizaron la amputación a nivel transtibial y a 29 (18,80?%) en supracondílea; 66 (42,80?%) eran fumadores y 102 (66,20?%) eran hipertensos. La HbA1c promedio fue del 10,1?%, cifra que fue superior en el grupo de amputados con 11,30?%. La creatinina promedio fue de 2,3 mg/dl y en el grupo de amputados fue de 3,5 mg/dl. El 72,30?% de los pacientes amputados eran hipertensos, mostrando una relación significativa con el riesgo de amputación (OR 2,2, IC = 1,10-4,37, P = 0,0244). Además, se encontró una asociación positiva entre el antecedente de amputación y el riesgo de sufrir otra durante la hospitalización (OR 3,41, IC = 1,56-7,45, P = 0,002). Conclusión: la enfermedad por pie diabético y la eventual amputación se relaciona con variables clínicas como la hipertensión y el antecedente de amputación, sumado a los resultados paraclínicos de los pacientes, como su control glicémico y sus niveles de creatinina.

Introducción. El consumo de café ha sido vinculado con desenlaces negativos en salud pero, en la actualidad, existe evidencia sobre efectos preventivos de desenlaces cardiovasculares en pacientes con diabetes mellitus tipo 2. Objetivo. Realizar búsqueda, comparación y resumen de la evidencia sobre el efecto del consumo habitual de café en la prevención de desenlaces cardiovasculares en pacientes con diabetes tipo 2. Métodos. Revisión de la literatura de artículos obtenidos en bases de datos: Google Scholar, PubMed, Scopus y Science Direct, publicados en inglés o español, complementada manualmente con referencias de los artículos citados. Resultados. Se realizó una revisión de la literatura de 12 artículos científicos, que incluyeron metaanálisis, estudios de cohorte y observacionales transversales centrados en los efectos benéficos del consumo de café en la población diabética. El consumo de café inhibe la enzima glucosa-6-fosfatasa reguladora de los niveles de glucosa y reduce la rigidez arterial, lo cual se asocia a menor riesgo de enfermedad cerebrovascular y mortalidad cardiovascular. Conclusión. El café contiene propiedades vasodilatadoras, antiinflamatorias y antioxidantes, las cuales pueden estar relacionadas con sus beneficios cardiovasculares en pacientes con diabetes tipo 2. A partir de esta revisión

El estudio presenta el caso de una mujer de 47 años con diabetes tipo 2 (DM-II), hipertensión y anemia, tratada con metformina, glibenclamida, metoprolol y hierro/ácido fólico. Se identificó una interacción farmacológica entre glibenclamida y metoprolol, causando síntomas de hipoglucemia por la tarde. La evaluación mediante la Escala de Probabilidad de Interacciones Farmacológicas (EPIF) de Horn sugirió una interacción probable. El análisis farmacocinético reveló que el tiempo en el cual se alcanzan las concentraciones máximas de ambos fármacos coincidía con el inicio de los síntomas. Se implementó un nuevo horario de medicación que resolvió los síntomas. La interacción farmacológica se atribuyó al bloqueo de los efectos adrenérgicos por el metoprolol, comprometiendo la capacidad de contrarrestar la acción de la insulina liberada por la glibenclamida. Se resalta la importancia de la vigilancia, la toma de decisiones informadas y la implementación de estrategias preventivas para garantizar la seguridad y eficacia del tratamiento farmacológico en pacientes con condiciones clínicas específicas, como la DM-II y enfermedades cardiovasculares concomitantes.

Objetivo: Avaliar a efetividade dos medicamentos inibidores da SGLT2 (iSGLT2) no controlo de pessoa com diabetes tipo 2 (PDM2) pelos valores de hemoglobina A1c (HbA1c), índice de massa corporal (IMC) e perímetro abdominal (PA) após cinco anos de seguimento. Métodos: Estudo observacional de coorte retrospetiva multicêntrica, de 2017 a 2022, efetuado em 2023. Analisaram-se os dados fornecidos pela Administração Regional de Saúde (ARS) do Centro de PDM2 (classificação T90 da ICPC-2) dos Agrupamentos de Centros de Saúde (ACeS) Baixo Mondego e Dão Lafões, de PMD2 escolhidas aleatoriamente e medicadas em 2017 com iSGLT2. Dados de PDM2 em 2017 e 2022, para a data mais próxima do fim do respetivo ano para HbA1c, IMC e PA. Controlo de DM2 para valores de HbA1c: ≤7% e ≤8%. Resultados: Amostra de n=264 pessoas, 59,0% (n=156) homens. Verificaram-se variações de 2017 para 2022 na HbA1c de 7,62±1,21 para 7,56±1,12 (∆=-0,009) (p=0,951), no IMC de 31,65±8,72 para 29,90±4,56 (∆=-0,056) (p0,05) e para HbA1c ≤8% de 74,8% em 2017 e de 73,3% em 2022, ∆=-0,02 (p=0,002). Discussão: Comparando com valores de um estudo prévio, com seguimento a dois anos, verificaram-se reduções em HbA1c e IMC e aumento do PA, provavelmente pelo facto de a sarcopenia reduzir o IMC, que o aumento do PA não contrabalança. A prescrição de iSGLT2 não reduziu a prevalência de PMD2. Conclusão: Verificou-se efetividade dos iSGLT2 na redução da HbA1c e do IMC, ao contrário do PA e da percentagem de PMDM2 controladas pelo valor de HbA1c.

Introdução: Com as mudanças no estilo de vida e exigências da sociedade moderna, a redução do tempo e da qualidade do sono têm se tornado comuns, paralelamente ao aumento da prevalência de obesidade e doenças crônicas não transmissíveis. Objetivo: Descrever a duração e qualidade do sono e relacioná-las ao índice de massa corporal, circunferência da cintura e percentual de gordura corporal em pacientes com doenças crônicas não transmissíveis. Materiais e métodos: Estudo transversal com pacientes de um ambulatório de Nutrição. A duração e a qualidade do sono foram avaliadas através de questionário. As variáveis idade, sexo, altura, índice de massa corporal e circunferência da cintura foram obtidas na anamnese padrão do serviço. O peso e o percentual de gordura corporal foram obtidos por bioimpedância elétrica. Foi testada a associação entre duração e qualidade do sono autorrelatadas com índice de massa corporal, circunferência da cintura e percentual de gordura corporal. Para as associações estatísticas, foi adotado um nível de significância de 5%. Resultados e discussão: Foram avaliados 69 pacientes, a maioria do sexo feminino (66,7%) e adultos (58%). A duração média do sono foi de 6,81 horas. A maioria (34,8%) dos pacientes relatou ter qualidade de sono sempre boa, sendo esse percentual maior entre os homens do que entre as mulheres (p=0,0077). Não houve associação entre tempo ou qualidade de sono e variáveis antropométricas. Conclusão: Apesar da baixa duração média de sono dos participantes não houve associação entre duração e qualidade do sono autorrelatadas com as variáveis antropométricas avaliadas.

Introducción: El uso de mHealth puede mejorar la adherencia a el automonitoreo con glucometría capilar (GC) en la transición del ámbito hospitalario al ambulatorio. Objetivo: evaluar la adherencia al automonitoreo con GC de los pacientes con Diabetes Tipo 2 (DM2) vinculados a un programa de educación usuarios de mHealth (ClouDi) comparado con el programa de educación y seguimiento presencial usual. Materiales y métodos: Estudio longitudinal prospectivo. Se analizaron pacientes con DM2 valorados por consulta de educación de diabetes con indicación de tratamiento con insulina al egreso hospitalario. Se analizaron dos grupos: uno con seguimiento presencial y otro vinculado a un programa educativo y uso de ClouDi. Resultados: De los 86 pacientes (44% de sexo femenino, 41 usuarios ClouDi, edad promedio 58.8 ± 11.2 años, con una media de duración de la diabetes de 7.8 ± 7.4 años), 53.6% se encontraban en estrato 2, el 92.9% pertenecían al régimen contributivo, el 42.9% con educación básica primaria y 51.2% empleados. Fue considerada la adherencia a la GC al realizar y registrar 3 o más mediciones por día en los pacientes de ClouDi fue mayor comparado con los pacientes en cuidado usual (64.4% vs 28.2%, p

Fundamento: la diabetes mellitus tipo 2 constituye una epidemia en aumento y supone una carga económica sustancial para los sistemas de salud. Detectar la enfermedad en una etapa temprana ayuda a reducir los costos médicos y el riesgo de que los pacientes tengan problemas de salud más complicados. Objetivo: diseñar un modelo matemático para la predicción de la probabilidad de existencia de diabetes mellitus tipo 2 en pacientes atendidos en un hospital de Guayaquil, Ecuador. Método: se realizó un estudio descriptivo y transversal. La población estuvo conformada por 324 pacientes. El procedimiento estadístico se basó en la aplicación de la regresión logística binaria. Para evaluar la capacidad predictiva del modelo, se empleó la prueba Kappa de Cohen. Resultados: la hipertensión arterial fue un factor de riesgo positivo para la diabetes mellitus tipo 2, con un coeficiente de probabilidad de 1,415. Los antecedentes familiares positivos incidieron en el aumento de la probabilidad. El consumo de alcohol fue un factor de riesgo positivo y el coeficiente de 0,790 indicó cuánto contribuyó al aumento de la probabilidad. El coeficiente Kappa, tuvo un valor de 0,434; con T aproximada de 7,809 y p < 0,001, indicó mayor prevalencia que sesgo y una mayor concordancia entre lo predicho en el modelo y lo observado. Conclusiones: la presencia de hipertensión arterial, antecedentes familiares positivos y el consumo de alcohol fueron factores significativos que aumentaron la probabilidad de desarrollar diabetes mellitus tipo 2. Es importante la detección temprana y la gestión de estos factores de riesgo en la prevención y el manejo de la enfermedad.

Objetivo: identificar os fatores que podem interferir na adesão de pacientes diabéticos tipo 2 ao tratamento nutricional. Materiais e Métodos: trata- se de um estudo de revisão integrativa baseada em pesquisa bibliográfica. A pesquisa foi realizada no período de fevereiro a maio de 2022 e incluiu artigos originais de estudos realizados com indivíduos adultos e/ou idosos com DM2 de ambos os sexos, indexados nas bases de dados Biblioteca Virtual em Saúde (BVS) e Science Direct, utilizando os descritores: adesão ao tratamento; terapia nutricional; diabetes mellitus tipo 2 e diabetes do tipo 2. Resultados: após o processo de análise, foram selecionados 4 artigos. Não ter recebido orientações sobre a alimentação adequada ou dificuldade de compreensão ou de seguir as orientações recebidas foram os principais fatores associados à não adesão ao tratamento dietético, referidos em três dos estudos analisados. Além destes, alguns dos fatores limitantes para aderir adequadamente à dieta incluem questões emocionais e problemas econômicos. Conclusão: é necessário que os profissionais de saúde tenham conhecimento do perfil dos seus pacientes, levando em consideração suas características e particularidades, e que passem orientações utilizando uma linguagem clara e acessível ao público-alvo, afim de que se haja uma melhor condução e adesão ao tratamento.

Objetivo: Identificar las estrategias de afrontamiento de un grupo de adultos con diabetes mellitus tipo 2 de una comunidad urbana de Tamaulipas. Metodología: Estudio descriptivo-trasversal, llevado a cabo en 215 adultos portadores de diabetes mellitus tipo2. Se aplicó una cedula de datos sociodemográficos y el Inventario de Estrategias de Afrontamiento (CSI). Los datos se procesaron con el paquete estadístico SPSS versión 21. Investigación sustentada bajo las normas de la Ley General de Salud en Materia de Investigación en México. Resultados: Prevaleciendo la participación del sexo femenino con un 72.09%. El 58.13%% poseen adecuadas estrategias de afrontamiento, el 35.37% poseen buenas estrategias de afrontamiento, el resto malas estrategias de afrontamiento. Por dominios el 43.7% presentaron adecuada y buena resolución de problemas, el 66.0% presento baja autocritica. 72.5% tuvo adecuada expresión emocional. El 79.0% presento pensamientos desiderativos, 55.3% tiene buen apoyo social, 32.0% presento baja reestructuración cognitiva. El 45.1% y 33.9% presento insuficiente y baja evitación de problemas respectivamente. Y el 66.0% y 30.6% tenía negativa y moderada retirada social respectivamente. Conclusiones: Las estrategias de afrontamiento se deben considerar como aquellas demandas tanto físicas como mentales que hay que poner en práctica para favorecer la calidad de vida de las personas que padecen una enfermedad crónica, ya que es una parte decisiva para avanzar o estancarse en el manejo de la enfermedad la cual no es transitoria sino permanente y al no tratarla adecuadamente provoca complicaciones de diferente índole, afectando todas las esferas de la persona.

Copyright of Revista de Ciencias Médicas de Pinar del Río is the property of Editorial Ciencias Medicas and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Analyze the scientific publications on the EQ-5D-5L scale that assesses QoL in patients with type 2 Diabetes Mellitus. This is an integrative review built through the intersection of the following Health Sciences Descriptors (DeCS/MeSH): "Type 2 Diabetes Mellitus"; "Quality of life"; "Impact"; "Personal satisfaction" and their English equivalents "Type 2 Diabetes Mellitus", "Quality of life", "Impact" and "Personal satisfaction". The terms were combined using the Boolean operators "and" or "or". Data collection took place from September to October 2023. Manuscripts published between 2006 and 2023, which consisted of quantitative studies written exclusively in English, were meticulously examined. That analysis encompassed eight investigations that converged on the conclusion that patients diagnosed with DM2 have a compromised QoL. A notable aspect highlighted by the studies is the disparity between men and women affected by DM2, with women experiencing a particularly significant reduction in quality of life. That phenomenon was quantified using the EQ-5D-5L scale. Those results highlight the importance of differentiated and personalized approaches for both sexes in the management and support of patients with DM2. Exploring the different dimensions of quality of life in patients with DM2 goes beyond a mere challenge; represents a significant advance for the multidisciplinary team, emphasizing the importance of a collective approach. This expanded perspective enables a more comprehensive understanding of the needs and impacts on patients' lives, encouraging more integrated and effective action by health professionals. [ABSTRACT FROM AUTHOR]

Type 2 diabetes mellitus (DM2) is recognized as a very important public health problem given its high prevalence and elevated morbidity and mortality. Cardiovascular disease is the main cause of death in patients with DM2, a list headlined by ischemic events; however, arrhythmias, also contribute notoriously to the mortality attributable to DM2. In general, the risk of developing an arrhythmia is much greater in the diabetic population in comparison with the general population. Although the most prevalent arrhythmia in diabetics is sinus tachycardia, it should be noted that blocks and atrial fibrillation are also frequent in this population. This is a key point, as having any kind of arrhythmia significantly increases the risk of sudden death, which has been demonstrated to be much more frequent in diabetics. Although the origin of arrhythmias in the context of DM2 has many pathophysiologic components, fluctuations in glycemia and oxidative stress appear to play the most important role. In order to reduce the incidence of arrhythmias through therapeutic measures, further research is needed to selectively approach these arrhythmogenic mechanisms. The objective of this review is to evaluate the pathophysiologic mechanisms related to DM2 that originate cardiac rhythm disorders; and to analyze their epidemiology in diabetic patients. [ABSTRACT FROM AUTHOR]

Currently, the field of phytopharmacology has demonstrated the antidiabetic potential of several traditional plants, including Pseudoelephantopus spicatus (amargon); however, studies demonstrating the hypoglycemic effect of this plant are little known. Therefore, in the present study, its glycemia-regulating effect was evaluated in a Wistar rat model. The experiments were performed as a pilot test and were validated in a kinetic of 0, 1, 1, 2, 6 and 24 hours using five experimental groups (control, diabetics induced with alloxan, diabetics treated with metformin and diabetics treated with P. spicatus extract with doses of 250 and 500 mg/kg). The treatments were applied for 1, 5 and 21 days and the data obtained were validated by ANOVA/Neuman-Keuls (p< 0.05) using the GraphPad Prism V.5. statistical package. The results showed that alloxan at 120 mg/kg induced diabetes mellitus in 100 % of the rats. The extract at 250 and 500 mg/kg achieved a significant reduction in blood glucose levels compared to diabetic rats, showing no significant difference between doses. The reduction in blood glucose levels caused by metformin at 500 mg/kg p< 0,05, and the different doses of the extract showed no significant differences. According to the results of the study, the extract of P. spicatus induces a hypoglycemic effect in rats. [ABSTRACT FROM AUTHOR]

Introduction: Nurse-led programs have a determinant role in the engagement of individuals in the self-management of type 2 diabetes mellitus (T2DM), as they contribute to improving quality of life. Self-management assisted by social support is vital, especially as it describes the importance of nurses in promoting health for people with T2DM, as this intervention can help reduce the consequences and progression of the disease. Objective: To map programs focused on nurse-led social support for people with T2DM. Materials and Methods: This is a scoping review in line with the methodological guidelines of the Joanna Briggs Institute. The search descriptors used were "autocuidado" (self-care), "intervenção liderada por enfermeiro" (nurse-led intervention), and "diabetes mellitus tipo 2" (type 2 diabetes mellitus), with searches in the Web of Science, Medline, CINAHL, Capes Theses and Dissertations Catalog, Scopus, JBI Evidence Synthesis, PsycINFO, and the Portuguese Open Access Scientific Repositories databases conducted between February and March 2022. The eligibility criteria were studies published within the last 10 years, in English, Spanish, and Portuguese, covering the individual's experience in programs focused on self-management through nurse-led social support. Results: A total of 12 studies were included, all of which were published in the United States, England, and Iran, focusing on social support for self-management in people with T2DM, and centered on care facilities for people with chronic diseases. It was found that most nurse-led programs have been implemented in developed countries and that their main characteristic is their emphasis on social cognitive theory. The population was characterized by being mostly women, aged over 22, with a low level of education. Conclusions: The study met the proposed objective by demonstrating that, despite the low implementation cost with high social and economic returns, the development of these programs is still scarce. The need for further studies focusing on emotional levels, such as depression and anxiety, is highlighted. [ABSTRACT FROM AUTHOR]

Objective: to identify the factors that may interfere with the adherence of type 2 diabetic patients to nutritional treatment. Materials and Methods: this is an integrative review study based on bibliographical research. The research was carried out from February to May 2022 and included original articles from studies carried out with adults and/or elderly individuals with DM2 of both genders, indexed in the Virtual Health Library (VHL) and Science Direct databases, using descriptors: adherence to treatment; nutritional therapy; type 2 diabetes mellitus and type 2 diabetes. Results: after the analysis process, 4 articles were selected. Not having received guidance on proper nutrition or difficulty understanding or following the guidance received were the main factors associated with non-adherence to dietary treatment, referred to in three of the analyzed studies. In addition to these, some of the limiting factors for properly adhering to the diet include emotional issues and economic problems. Conclusion: it is necessary that health professionals are aware of the profile of their patients, taking into account their characteristics and particularities, and that they provide guidelines using clear and accessible language for the target audience, so that there is a better conduction and adherence to the treatment. [ABSTRACT FROM AUTHOR]